Concepedia
Statistics
Publications
17
Citations
911
H-Index
15
Active since
1991
Affiliations
Erasmus University Rotterdam(Current)
Erasmus MC
Leiden University
The Netherlands Cancer Institute
Radboud University Nijmegen
M. van Vliet is an author at Erasmus University Rotterdam specializing in medicine, genetics, and pharmacogenetics.
Publications per year
1991–2014
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
Christophe Desmet, Tristan Gallenne, Alexandre Prieur et al. · Proceedings of the National Academy of Sciences · 2013 · 183 citations
Medicine, Molecular Biology, Oncology +17
The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon
Loes E. Visser, M. van Vliet, Ron HN van Schaik et al. · Pharmacogenetics · 2003 · 101 citations
Medicine, Pharmacokinetics, Pharmacology +16
The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon
Loes E. Visser, Ron HN van Schaik, M. van Vliet et al. · Thrombosis and Haemostasis · 2004 · 90 citations
Medicine, Pharmacokinetics, Pharmacology +15
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
R.S. Cornelis, M. van Vliet, C.B.J. Vos et al. · PubMed · 1994 · 88 citations
Life Sciences, Genetics, Molecular Genetics +14
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms
M-D Levin, Jan G. den Hollander, Bronno van der Holt et al. · Journal of Antimicrobial Chemotherapy · 2007 · 84 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +17
1–5 of 17